NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054076

Registered date:12/05/2024

Combination therapy under high and very high power short duration ablation: efficacy and safety evaluation

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedatrial fibrillation
Date of first enrollment2024/04/03
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)This group comprised of the patients who had undergone their first atrial fibrillation ablation using QDOT MICRO catheter under high and very high power ablation. This group comprised of the patients who had undergone their first atrial fibrillation ablation using SMART TOUCH SF(current ablation catheter) catheter under high power ablation.

Outcome(s)

Primary Outcomeevaluation of Initial line isolation evaluation of stroke following catheter ablation
Secondary Outcomeatrial fibrillation recurrence rate during 1 year follow-up period

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients who could not obtain informed consent.

Related Information

Contact

public contact
Name Tadashi Hoshiyama
Address 1-1-1 honjo Kumamoto city Japan 860-8556
Telephone 096-373-5175
E-mail tadashi@kumamoto-u.ac.jp
Affiliation Department of Cardiovascular medicine, Kumamoto University Hospital Cardiovascular medicine
scientific contact
Name Kenichi Tsujita
Address 1-1-1 honjo kumamoto city Japan
Telephone 096-373-5175
E-mail tsujita@kumamoto-u.ac.jp
Affiliation Department of Cardiovascular medicine, Kumamoto University Hospital Cardiovascular medicine